A preventative FOXP3 DNA ecombinant protein vaccine can promote immunity against Tregs in the absence of a tumor, enhancing the immune response against the tumor by targeting Tregs and Myeloid-derived suppressor cells (MDSCs). The gene discussed is FOXP3; the disease is neoplasm.